Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma

Fig. 1

The flow chart demonstrates the patient selectin on this study. During the period from December 2007 to December 2012, 385 consecutive esophageal cancer patients underwent a surgical resection at our institution. The patients with other histopathological finding without SCC were excluded because SCC is the predominant histologic type of esophageal cancer, accounting for approx. 90% of all cases; non-SCC patients are rare. SCC: squamous cell carcinoma, NAC: neoadjuvant chemotherapy, NACRT: neoadjuvant chemoradiotherapy, ESCC: esophageal squamous cell carcinoma

Back to article page